Cargando…
Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada
After treatment, cancer survivors require ongoing, comprehensive care to improve quality of life, reduce disability, limit complications, and restore function. In Canada and internationally, follow-up care continues to be delivered most often by oncologists in institution-based settings. There is ex...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139666/ https://www.ncbi.nlm.nih.gov/pubmed/35621651 http://dx.doi.org/10.3390/curroncol29050261 |
_version_ | 1784714912681951232 |
---|---|
author | Urquhart, Robin Cordoba, Wendy Bender, Jackie Cuthbert, Colleen Easley, Julie Howell, Doris Kaal, Julia Kendell, Cynthia Radford, Samantha Sussman, Jonathan |
author_facet | Urquhart, Robin Cordoba, Wendy Bender, Jackie Cuthbert, Colleen Easley, Julie Howell, Doris Kaal, Julia Kendell, Cynthia Radford, Samantha Sussman, Jonathan |
author_sort | Urquhart, Robin |
collection | PubMed |
description | After treatment, cancer survivors require ongoing, comprehensive care to improve quality of life, reduce disability, limit complications, and restore function. In Canada and internationally, follow-up care continues to be delivered most often by oncologists in institution-based settings. There is extensive evidence to demonstrate that this model of care does not work well for many survivors or our cancer systems. Randomized controlled trials have clearly demonstrated that alternate approaches to follow-up care are equivalent to oncologist-led follow-up in terms of patient outcomes, such as recurrence, survival, and quality of life in a number of common cancers. In this paper, we discuss the state of follow-up care for survivors of prevalent cancers and the need for more personalized models of follow-up. Indeed, there is no one-size-fits-all solution to post-treatment follow-up care, and more personalized approaches to follow-up that are based on individual risks and needs after cancer treatment are warranted. Canada lags behind when it comes to personalizing follow-up care for cancer survivors. There are many reasons for this, including difficulty in determining who is best served by different follow-up pathways, a paucity of evidence-informed self-management education and supports for most survivors, poorly developed IT solutions and systems, and uneven coordination of care. Using implementation science theories, approaches, and methods may help in addressing these challenges and delineating what might work best in particular settings and circumstances. |
format | Online Article Text |
id | pubmed-9139666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91396662022-05-28 Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada Urquhart, Robin Cordoba, Wendy Bender, Jackie Cuthbert, Colleen Easley, Julie Howell, Doris Kaal, Julia Kendell, Cynthia Radford, Samantha Sussman, Jonathan Curr Oncol Commentary After treatment, cancer survivors require ongoing, comprehensive care to improve quality of life, reduce disability, limit complications, and restore function. In Canada and internationally, follow-up care continues to be delivered most often by oncologists in institution-based settings. There is extensive evidence to demonstrate that this model of care does not work well for many survivors or our cancer systems. Randomized controlled trials have clearly demonstrated that alternate approaches to follow-up care are equivalent to oncologist-led follow-up in terms of patient outcomes, such as recurrence, survival, and quality of life in a number of common cancers. In this paper, we discuss the state of follow-up care for survivors of prevalent cancers and the need for more personalized models of follow-up. Indeed, there is no one-size-fits-all solution to post-treatment follow-up care, and more personalized approaches to follow-up that are based on individual risks and needs after cancer treatment are warranted. Canada lags behind when it comes to personalizing follow-up care for cancer survivors. There are many reasons for this, including difficulty in determining who is best served by different follow-up pathways, a paucity of evidence-informed self-management education and supports for most survivors, poorly developed IT solutions and systems, and uneven coordination of care. Using implementation science theories, approaches, and methods may help in addressing these challenges and delineating what might work best in particular settings and circumstances. MDPI 2022-05-03 /pmc/articles/PMC9139666/ /pubmed/35621651 http://dx.doi.org/10.3390/curroncol29050261 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Urquhart, Robin Cordoba, Wendy Bender, Jackie Cuthbert, Colleen Easley, Julie Howell, Doris Kaal, Julia Kendell, Cynthia Radford, Samantha Sussman, Jonathan Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title | Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title_full | Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title_fullStr | Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title_full_unstemmed | Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title_short | Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada |
title_sort | risk stratification and cancer follow-up: towards more personalized post-treatment care in canada |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139666/ https://www.ncbi.nlm.nih.gov/pubmed/35621651 http://dx.doi.org/10.3390/curroncol29050261 |
work_keys_str_mv | AT urquhartrobin riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT cordobawendy riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT benderjackie riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT cuthbertcolleen riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT easleyjulie riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT howelldoris riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT kaaljulia riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT kendellcynthia riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT radfordsamantha riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada AT sussmanjonathan riskstratificationandcancerfollowuptowardsmorepersonalizedposttreatmentcareincanada |